Latest return on equity
NewAmsterdam Pharma Return on equity
Direct answer
NewAmsterdam Pharma's return on equity is -36.81%.
The verified market snapshot reports -36.81%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 12, 2026.
Get free NewAmsterdam Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -36.81%
Explore related company data
View NewAmsterdam Pharma's market capitalizationView NewAmsterdam Pharma's price-to-book ratioView NewAmsterdam Pharma's 52-week price rangeView NewAmsterdam Pharma's revenue growthView NewAmsterdam Pharma's profit marginView NewAmsterdam Pharma's debt-to-equity ratioView all NewAmsterdam Pharma key metricsReturn to NewAmsterdam Pharma profile